» Articles » PMID: 1180576

The Early Diagnosis of Medullary Carcinoma of the Thyroid Gland in Patients with Multiple Endocrine Neoplasia Type II

Overview
Journal Ann Surg
Specialty General Surgery
Date 1975 Oct 11
PMID 1180576
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Pentagastrin is a potent stimulator of thyrocalcitonin secretion from "C" cells. Since medulllary carcinoma of the thyroid gland (MCT) is a tumor composed of "C" cells, pentagastrin was used to screen a large kindred with multiple endocrine neoplasia type II (MCT, pheochromocytoma (s), and parathyroid hyperplasia). Four children with no thyroid abnormalities evident on physical examination, with negative thyroid scans, and with normal levels of plasma thyrocalcitonin both before and after calcium infusion, were found to have elevated peripheral levels of this hormone following pentagastrin injection. All four children were found to have very small foci of MCT, in both thyroid lobes at the time of total thyroidectomy. Pentagastrin stimulation used conjointly with selective catheterization of the inferior thyroid vein provided even greater diagnostic accuracy in detecting elevations in thyrocalcitonin secretion. This test has great diagnostic utility, especially in screening patients with multiple endocrine neoplasia type II.

Citing Articles

Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test".

Niederle M, Scheuba C, Gessl A, Li S, Koperek O, Bieglmayer C Biochem Med (Zagreb). 2018; 28(3):030710.

PMID: 30429678 PMC: 6214694. DOI: 10.11613/BM.2018.030710.


Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.

Dralle H, Damm I, Scheumann G, Kotzerke J, Kupsch E, Geerlings H Surg Today. 1994; 24(2):112-21.

PMID: 8054788 DOI: 10.1007/BF02473391.


Sipple syndrome: marked variability of the disease within a family and implications for management.

Stevenson J, Hillyard C, Spanos E, MacIntyre I, Ackroyd N, Lynn J Postgrad Med J. 1981; 57(664):104-8.

PMID: 7267504 PMC: 2424808. DOI: 10.1136/pgmj.57.664.104.


Basal and pentagastrin-stimulated levels of calcitonin in thyroid and peripheral veins during normocalcemia and chronic hypercalcemia in humans.

Ericsson M, Berg M, Ingemansson S, Jernby B, Jarhult J Ann Surg. 1981; 194(2):129-33.

PMID: 7259337 PMC: 1345228. DOI: 10.1097/00000658-198108000-00002.


Thyroid venous catheterization in the early diagnosis of familial medullary thyroid carcinoma.

Wells Jr S, Baylin S, Johnsrude I, Harrington D, Mendelsohn G, Ontjes D Ann Surg. 1982; 196(5):505-11.

PMID: 7125737 PMC: 1352780. DOI: 10.1097/00000658-198211000-00001.


References
1.
HAZARD J, HAWK W, CRILE Jr G . Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab. 1959; 19(1):152-61. DOI: 10.1210/jcem-19-1-152. View

2.
TASHJIAN Jr A, Melvin E . Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts. N Engl J Med. 1968; 279(6):279-83. DOI: 10.1056/NEJM196808082790602. View

3.
Steiner A, Goodman A, Powers S . Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2. Medicine (Baltimore). 1968; 47(5):371-409. DOI: 10.1097/00005792-196809000-00001. View

4.
Williams E, Karim S, Sandler M . Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea. Lancet. 1968; 1(7532):22-3. DOI: 10.1016/s0140-6736(68)90010-x. View

5.
MELVIN K, TASHJIAN Jr A, Miller H . Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res. 1972; 28:399-470. View